Anthropic is AI trade's last big hope for a major IPO this year

Kalshi traders give Anthropic a 75% chance of officially announcing an IPO in 2026, while odds for Plaid, Deel, Databricks and OpenAI have fallen to 10%, 3%, 1% and 3%, respectively. Despite IPO proceeds being up sharply, the number of U.S. IPOs priced this year is down 33% versus 2025, according to Renaissance Capital. Anthropic reported third-quarter revenue of $16.8 billion, with slower quarter-over-quarter growth; its revised IPO valuation range reportedly starts at $1.5 trillion versus prior expectations of at least $2 trillion, adding pressure to AI-related equities.

Analysis

The key read-through is not simply fewer listings; it is a wider gap between private marks and what public investors will underwrite. If growth decelerates while LLM pricing compresses, late-stage AI valuations and private-fund marks face pressure before any IPO actually occurs. That creates a near-term overhang for venture-backed technology exposure and IPO-related sentiment, with potential spillover to AI infrastructure names if investors revise expectations for monetization and capital needs. The counterpoint: delayed listings preserve scarcity and defer public-market supply; proceeds can remain concentrated in a few megadeals rather than signaling a broad reopening.

Over the next 1–3 months, Anthropic’s filing terms and evidence explaining revenue growth are more useful catalysts than prediction-market odds. A high valuation paired with slowing growth could reset AI multiples; a credible explanation of the slowdown or resilient demand could reverse the sentiment hit. Over 6–18 months, sustained private funding access would weaken the urgency to list, while tighter financing or a receptive public window could release a backlog of supply. Kalshi probabilities are not a clean demand indicator: resolution depends on formal listing milestones, and the platform’s commercial relationship with CNBC is a reason to treat the cited odds cautiously.

The contrarian point is that IPO proceeds can rise even as listing breadth contracts, so aggregate proceeds alone may overstate market health. The article provides no basis to infer SpaceX-specific fundamentals or to trade SPCX directionally; it is an outlier, not a proxy for the IPO pipeline.

Key Decisions for Investors

• Avoid a broad IPO-sector short solely on this report. The signal is strongest for private-market valuation risk, while a thin pipeline can also limit near-term public supply.
• Treat Anthropic’s eventual filing and pricing as the key 1–3 month event: consider a conditional short/underweight in AI-growth exposure only if terms imply premium expectations and subsequent disclosures confirm decelerating growth or pricing pressure. Reassess if demand and monetization evidence stabilize.
• Keep SPCX exposure driven by company-specific valuation, liquidity and lockup information; do not use it as a stand-in for weaker IPO breadth. Those data are not provided here.
• Falsifiers: improving AI revenue-growth disclosures or pricing resilience, a broad pickup in completed filings, or easier private financing would weaken the cautious thesis. Watch actual IPO terms and listing breadth rather than Kalshi odds.